Navigation Links
Eric K. Rowinsky Joins ADVENTRX Board of Directors
Date:2/25/2008

king Statements

ADVENTRX cautions you that statements included in this press release that are not a description of historical facts are forward-looking statements that involve risks and assumptions that, if they materialize or do not prove to be accurate, could cause ADVENTRX's results to differ materially from historical results or those expressed or implied by such forward-looking statements. These risks and uncertainties include, but are not limited to: the risk that ADVENTRX will be unable to raise sufficient capital to fund the projects necessary to meet its anticipated or stated goals and milestones; the risk that preclinical results are not indicative of the success of subsequent clinical trials and the results of pending clinical trials; the potential for ADVENTRX's product candidates to receive regulatory approval for one or more indications on a timely basis or at all, and the uncertain process of seeking regulatory approval; other difficulties or delays in manufacturing, marketing and obtaining regulatory approval for ADVENTRX's product candidates; the potential for regulatory authorities to require additional preclinical work or other clinical requirements to support regulatory filings; the market potential for ADVENTRX's product candidates and ADVENTRX's ability to compete in those markets; the scope and validity of patent protection for ADVENTRX's product candidates; patent and non-patent exclusivity covering Navelbine(R) and Taxotere(R); and other risks and uncertainties more fully described in ADVENTRX's press releases and periodic filings with the Securities and Exchange Commission. ADVENTRX's public filings with the Securities and Exchange Commission are available at http://www.sec.gov.

You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date when made. ADVENTRX does not intend to update any forward-looking statement as set forth i
'/>"/>

SOURCE ADVENTRX Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Roche Joins Forces With Enon Tabernacle Baptist Church to Provide Free Hepatitis C Testing to the Community
2. Ralf Rosskamp, M.D. Joins Biodels Scientific Advisory Board
3. Hank Plain Joins Morgenthaler Ventures as Partner
4. Legendary Earvin Magic Johnson Joins AFL/Signalife Cardiovascular Protection Team
5. Senior Research Analyst Richard Evans Joins AVOS Life Sciences
6. Dan Broderick Joins Prolog Ventures as Partner
7. Ingenuity Systems Joins Biomarkers Consortium
8. Founder of ILEX Oncology and Triton Biosciences, Richard Love, Joins Board of Directors of Cell Therapeutics, Inc. (CTI)
9. Glycominds Joins Biomolecular Photonic (BMP) Consortium to Develop New Molecular Imaging Technique
10. Progeniq Joins Microsoft in Bio IT Alliance
11. Jeffrey H. Buchalter Joins MacroGenics Board of Directors as Chairman

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)...ire-USNewswire/ -- The Michael J. Fox Foundation f...5 million in total awards to six research teams wo...rapies for Parkinson,s disease. The funding was aw...y for Parkinson,s Disease program, made possible ... ), a neuroscience-based biotechnology company. ,...
(Date:11/30/2009).../ -- Dr. Jessica Torrente, Assistant Professor of ...Center in Washington, D.C., demonstrated the integ...SGI) in clinical practice as an adjunct imaging mo... the annual meeting of the Radiological Society of...xhibit was to demonstrate how BSGI is used in the ...
(Date:11/30/2009)... in providing smart and efficient software to the ...reg;, evolutionizing work-from-home histopathology... software used by 8 of the Top 10 Pharmaceutical C...ide’ basis. , Mount...s announced another evolution in the histopatholog...
(Date:11/30/2009)...er 30 ApaTech, the rapidly growing...t growing,Biotech/Pharmaceutical/Medical Technolog...y Fast 500 for EMEA (Europe, Middle East and Afric...ompanies, five-year revenue growth,for which ApaT.... This,achievement places ApaTech 9th overall in t...
Breaking Biology Technology:The Michael J. Fox Foundation Announces $1.5 Million in Funding to Advance Development of Drug Targets for Disease-Modifying Parkinson's Disease Treatments 2The Michael J. Fox Foundation Announces $1.5 Million in Funding to Advance Development of Drug Targets for Disease-Modifying Parkinson's Disease Treatments 3Breast-Specific Gamma Imaging In Clinical Practice as an Adjunct Imaging Modality for Diagnosis of Breast Cancer 2Pajama Pathology -- the New Wave of Preclinical Pathology Embraced by PDS 2Pajama Pathology -- the New Wave of Preclinical Pathology Embraced by PDS 3ApaTech is Europe's Fastest Growing Lifescience Company 2ApaTech is Europe's Fastest Growing Lifescience Company 3ApaTech is Europe's Fastest Growing Lifescience Company 4
...PPLICATION NOTE , , Cathy Olsen,...s Dr., , Sunnyvale, CA 94089. , ...The Molecular Devices SpectraMax M5 and, ...microplate readers whose detection modes include,... have dual, monochromators, so the optimi...
... Application Guide .........................................................................2 , ........................................................, II. Product Components ................................................................2 ,...
...urification of Endotoxin-Free Plasmid DNA , ,D... HP Endotoxin-Free Plasmid Maxiprep,Kit offers a...in-free plasmid DNA. A patent-pending,endotoxin ...t streamlined protocol available for purifying,h....,This product delivers significant time-savings...
Other Biology Technology:measuring cell proliferation with SpectraMax M5, M2 and Gemini microplate readers using the CyQUANT Cell Proliferation Assay 2measuring cell proliferation with SpectraMax M5, M2 and Gemini microplate readers using the CyQUANT Cell Proliferation Assay 3measuring cell proliferation with SpectraMax M5, M2 and Gemini microplate readers using the CyQUANT Cell Proliferation Assay 4measuring cell proliferation with SpectraMax M5, M2 and Gemini microplate readers using the CyQUANT Cell Proliferation Assay 5measuring cell proliferation with SpectraMax M5, M2 and Gemini microplate readers using the CyQUANT Cell Proliferation Assay 6measuring cell proliferation with SpectraMax M5, M2 and Gemini microplate readers using the CyQUANT Cell Proliferation Assay 7measuring cell proliferation with SpectraMax M5, M2 and Gemini microplate readers using the CyQUANT Cell Proliferation Assay 8measuring cell proliferation with SpectraMax M5, M2 and Gemini microplate readers using the CyQUANT Cell Proliferation Assay 9measuring cell proliferation with SpectraMax M5, M2 and Gemini microplate readers using the CyQUANT Cell Proliferation Assay 10measuring cell proliferation with SpectraMax M5, M2 and Gemini microplate readers using the CyQUANT Cell Proliferation Assay 11measuring cell proliferation with SpectraMax M5, M2 and Gemini microplate readers using the CyQUANT Cell Proliferation Assay 12measuring cell proliferation with SpectraMax M5, M2 and Gemini microplate readers using the CyQUANT Cell Proliferation Assay 13measuring cell proliferation with SpectraMax M5, M2 and Gemini microplate readers using the CyQUANT Cell Proliferation Assay 14measuring cell proliferation with SpectraMax M5, M2 and Gemini microplate readers using the CyQUANT Cell Proliferation Assay 15Protocol for GenomePlex Whole Genome Amplification from Formalin-Fixed Parrafin-Embedded (FFPE) tissue 2Protocol for GenomePlex Whole Genome Amplification from Formalin-Fixed Parrafin-Embedded (FFPE) tissue 3Protocol for GenomePlex Whole Genome Amplification from Formalin-Fixed Parrafin-Embedded (FFPE) tissue 4Protocol for GenomePlex Whole Genome Amplification from Formalin-Fixed Parrafin-Embedded (FFPE) tissue 5Protocol for GenomePlex Whole Genome Amplification from Formalin-Fixed Parrafin-Embedded (FFPE) tissue 6Protocol for GenomePlex Whole Genome Amplification from Formalin-Fixed Parrafin-Embedded (FFPE) tissue 7Protocol for GenomePlex Whole Genome Amplification from Formalin-Fixed Parrafin-Embedded (FFPE) tissue 8Protocol for GenomePlex Whole Genome Amplification from Formalin-Fixed Parrafin-Embedded (FFPE) tissue 9Introducing,GenElute HP,Endotoxin-Free Plasmid,Maxiprep Kit 2Introducing,GenElute HP,Endotoxin-Free Plasmid,Maxiprep Kit 3Introducing,GenElute HP,Endotoxin-Free Plasmid,Maxiprep Kit 4Introducing,GenElute HP,Endotoxin-Free Plasmid,Maxiprep Kit 5
(Date:11/30/2009)...rom The Forsyth Institute, the University of Conne...nter, have used state-of-the-art technology to elu...lidum, the bacterium which causes syphilis. The pr...a can now be shown in three dimensions. This provi...ls previously unknown features, which may help fig...
(Date:11/30/2009)...rchers from LSU Health Sciences Center New Orleans...ational Institute of Child Health and Human Develo...igham and Women,s Hospital, and Harvard Medical Sc...more than 5 servings of sugar- sweetened cola a we...vate the risk of developing diabetes during pregna...
(Date:11/30/2009)...naugural Global Conference on Systems & Enterprise...gton, DC, focuses on the convergence of complex la...rtance to society. , The goal of the confere...round targeted complex systems, examined by domain...s Critical Infrastructure Systems, including Intel...
Breaking Biology News(10 mins):Scientists gain new understanding of disease-causing bacteria 2Sugary cola drinks linked for first time to higher risk of gestational diabetes 2Sugary cola drinks linked for first time to higher risk of gestational diabetes 3First global conference on systems and enterprises at new Stevens location, Washington, DC, Dec. 3-4 2Medpedia Project Expands Platform to Include Q 26amp 3BA News 26amp 3B Analysis and Alerts 61040 1Medpedia Project Expands Platform to Include Q 26amp 3BA News 26amp 3B Analysis and Alerts 61040 2Medpedia Project Expands Platform to Include Q 26amp 3BA News 26amp 3B Analysis and Alerts 61040 3Medpedia Project Expands Platform to Include Q 26amp 3BA News 26amp 3B Analysis and Alerts 61040 4Top 10 Tips for Alzheimer 26apos 3Bs Caregivers 61036 1Top 10 Tips for Alzheimer 26apos 3Bs Caregivers 61036 2Ironwood and Astellas Announce Japan Licensing Agreement for Linaclotide 6117 1Ironwood and Astellas Announce Japan Licensing Agreement for Linaclotide 6117 2Ironwood and Astellas Announce Japan Licensing Agreement for Linaclotide 6117 3
...p-selling laundry products and air fresheners foun...ls. All six products tested gave off at least one ...eral laws, but none of those chemicals was listed ...n this topic because people were telling me that t...t from laundry products vented outdoors were makin...
...e working on new ways of storing CO 2 emissions u...ming. , The University has launched the Carbon St...ly-created position of Professor of Carbon Capture...to find efficient and reliable ways of gathering C...ng it in former oil and gas fields or aquifers ind...
...om the lower abdomen and inner thigh through lipos... cells, with higher stem cell concentrations than ... study in August,s Plastic and Reconstructive Sur...n Society of Plastic Surgeons (ASPS). This is the ...sues from different areas of the body vary in stem...
Other Biology News:Toxic chemicals found in common scented laundry products, air fresheners 2Toxic chemicals found in common scented laundry products, air fresheners 3Durham scientists to tackle CO2 storage in global warming challenge 2Want a reason to love your lower belly fat? It's rich in stem cells 2
Normal Chicken Serum from Equitech-Bio
Mouse Anti-Human HAPLN1 Monoclonal Antibody, Unconjugated, Clone 316119 from R&D Systems
Anti-Myelin Basic Protein (MBP), aa 129-138 Monoclonal Antibody, Unconjugated, Clone clone 1 from CHEMICON
SEQUENASE PCR PRODUCT PRE-SEQU from GE Healthcare, formerly Amersham Biosciences
Biology Products: